Randomized, double-blind, placebo-controlled dose-finding study of the dipeptidyl peptidase-4 inhibitor linagliptin in pediatric patients with type 2 diabetes.
about
Randomized, double-blind, placebo-controlled dose-finding study of the dipeptidyl peptidase-4 inhibitor linagliptin in pediatric patients with type 2 diabetes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Randomized, double-blind, plac ...... patients with type 2 diabetes.
@en
Randomized, double-blind, plac ...... patients with type 2 diabetes.
@nl
type
label
Randomized, double-blind, plac ...... patients with type 2 diabetes.
@en
Randomized, double-blind, plac ...... patients with type 2 diabetes.
@nl
prefLabel
Randomized, double-blind, plac ...... patients with type 2 diabetes.
@en
Randomized, double-blind, plac ...... patients with type 2 diabetes.
@nl
P2093
P2860
P356
P1433
P1476
Randomized, double-blind, plac ...... patients with type 2 diabetes.
@en
P2093
Cornelia E Hoesl
Dietmar Neubacher
Jacques Weill
Jan Marquard
Lori Mb Laffel
Maud Gordat
Silke Retlich
Stefan Kaspers
Willem Hettema
P2860
P356
10.1111/PEDI.12616
P577
2017-11-24T00:00:00Z